Filings
Companies
Signals
News
Watches
Workspaces
Settings
Filings
Companies
Signals
News
Watches
Workspaces
Settings
Search
Cmd+K
Toggle theme
Login
BridgeBio Oncology Therapeutics, Inc. (BBOT) - 424B3 Filing (2026-04-23) | QuantVision
Back to BridgeBio Oncology Therapeutics, Inc.
424B3 Filing
BridgeBio Oncology Therapeutics, Inc.
•
Filed: 2026-04-23
•
0001193125-26-170973
Filing Reader
Normalized View
Loading filing...
Original Documents & Attachments (2)
Documents
Seq
Description
Type
Size
1
424B3
424B3
34.4 KB
Open in viewer
Download
999
Full raw SEC SGML submission
Full Submission Text
35.6 KB
Open in viewer
Download
Details
Period of Report
2026-04-23
Accepted
-
Original Source
SEC.gov Index
